Ken Fisher Halozyme Therapeutics, Inc. Transaction History

Fisher Asset Management, LLC

$227 Billion
Q1 2025

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 417,516 shares of HALO stock, worth $22.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

417,516

Previous 414,719 0.67%

Holding current value

$22.7 Million

Previous $19.8 Million 34.37%

% of portfolio

0.01%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$47.74 - $65.16 $133,528 - $182,252	2,797 Added 0.67%	417,516 $26.6 Million
Q4 2024 Feb 05, 2025	BUY	$42.57 - $61.09 $3.86 Million - $5.54 Million	90,714 Added 28.0%	414,719 $19.8 Million
Q3 2024 Nov 12, 2024	BUY	$51.3 - $64.42 $1.06 Million - $1.33 Million	20,721 Added 6.83%	324,005 $18.5 Million
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $991,075 - $1.37 Million	26,212 Added 9.46%	303,284 $15.9 Million
Q1 2024 May 09, 2024	BUY	$33.68 - $41.95 $5,725 - $7,131	170 Added 0.06%	277,072 $11.3 Million
Q4 2023 Mar 05, 2024	BUY	$33.32 - $42.1 $2,665 - $3,368	80 Added 0.03%	276,902 $10.2 Million
Q4 2023 Feb 06, 2024	BUY	$33.32 - $42.1 $52,878 - $66,812	1,587 Added 0.58%	276,822 $10.2 Million
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $5.62 Million - $6.78 Million	-154,084 Reduced 35.89%	275,235 $10.5 Million
Q2 2023 Dec 12, 2023	BUY	$30.28 - $38.74 $4.67 Million - $5.97 Million	154,084 Added 55.98%	429,319 $15.5 Million
Q2 2023 Aug 08, 2023	SELL	$30.28 - $38.74 $207,206 - $265,097	-6,843 Reduced 1.57%	429,319 $15.5 Million
Q1 2023 Dec 12, 2023	BUY	$32.86 - $55.7 $5.16 Million - $8.75 Million	157,074 Added 57.07%	432,309 $16.5 Million
Q1 2023 May 01, 2023	BUY	$32.86 - $55.7 $8,050 - $13,646	245 Added 0.06%	436,162 $16.7 Million
Q4 2022 Feb 03, 2023	SELL	$40.06 - $59.44 $10.1 Million - $15 Million	-253,083 Reduced 36.73%	435,917 $24.8 Million
Q3 2022 Nov 08, 2022	SELL	$38.53 - $51.78 $12.6 Million - $16.9 Million	-326,289 Reduced 32.14%	689,000 $27.2 Million
Q2 2022 Aug 09, 2022	BUY	$37.35 - $48.3 $2.76 Million - $3.56 Million	73,775 Added 7.84%	1,015,289 $44.7 Million
Q1 2022 May 05, 2022	SELL	$31.97 - $41.06 $38,875 - $49,928	-1,216 Reduced 0.13%	941,514 $37.5 Million
Q4 2021 Feb 02, 2022	SELL	$31.82 - $40.75 $2 Million - $2.56 Million	-62,708 Reduced 6.24%	942,730 $37.9 Million
Q3 2021 Oct 26, 2021	BUY	$38.47 - $46.42 $3.14 Million - $3.79 Million	81,724 Added 8.85%	1,005,438 $40.9 Million
Q2 2021 Jul 27, 2021	BUY	$38.84 - $51.31 $995,741 - $1.32 Million	25,637 Added 2.85%	923,714 $41.9 Million
Q1 2021 Apr 27, 2021	SELL	$39.51 - $51.45 $499,327 - $650,225	-12,638 Reduced 1.39%	898,077 $37.4 Million
Q4 2020 Jan 29, 2021	SELL	$25.81 - $43.62 $1.12 Million - $1.89 Million	-43,442 Reduced 4.55%	910,715 $38.9 Million
Q3 2020 Nov 10, 2020	SELL	$25.74 - $29.63 $2.64 Million - $3.04 Million	-102,514 Reduced 9.7%	954,157 $25.1 Million
Q2 2020 Aug 07, 2020	SELL	$16.25 - $26.81 $617,500 - $1.02 Million	-38,000 Reduced 3.47%	1,056,671 $28.3 Million
Q1 2020 Apr 28, 2020	SELL	$13.9 - $21.83 $1.22 Million - $1.92 Million	-87,992 Reduced 7.44%	1,094,671 $19.7 Million
Q4 2019 Feb 12, 2020	BUY	$14.93 - $19.53 $190,312 - $248,948	12,747 Added 1.09%	1,182,663 $21 Million
Q3 2019 Oct 29, 2019	BUY	$15.2 - $17.69 $102,691 - $119,513	6,756 Added 0.58%	1,169,916 $18.1 Million
Q2 2019 Jul 30, 2019	BUY	$14.75 - $17.26 $3.27 Million - $3.82 Million	221,470 Added 23.52%	1,163,160 $20 Million
Q1 2019 Apr 22, 2019	BUY	$13.94 - $17.58 $1.06 Million - $1.33 Million	75,771 Added 8.75%	941,690 $15.2 Million
Q4 2018 Jan 25, 2019	BUY	$13.33 - $18.66 $5.58 Million - $7.81 Million	418,581 Added 93.57%	865,919 $12.7 Million
Q3 2018 Oct 24, 2018	SELL	$16.68 - $18.41 $105,317 - $116,240	-6,314 Reduced 1.39%	447,338 $8.13 Million
Q2 2018 Jul 09, 2018	SELL	$16.87 - $20.3 $748,386 - $900,548	-44,362 Reduced 8.91%	453,652 $7.65 Million
Q1 2018 May 11, 2018	SELL	$17.06 - $21.2 $11.1 Million - $13.8 Million	-651,928 Reduced 56.69%	498,014 $9.76 Million
Q1 2018 Apr 19, 2018	BUY	$17.06 - $21.2 $10.1 Million - $12.5 Million	589,569 Added 105.21%	1,149,942 $22.5 Million
Q4 2017 Jan 24, 2018	SELL	$16.75 - $20.8 $382,704 - $475,238	-22,848 Reduced 3.92%	560,373 $11.4 Million
Q3 2017 Oct 17, 2017	BUY	$11.76 - $17.4 $6.86 Million - $10.1 Million	583,221	583,221 $10.1 Million

Others Institutions Holding HALO

# of Institutions

595

Shares Held

124M

Call Options Held

320K

Put Options Held

113K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.58B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account